Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland
NCT ID: NCT01150240
Last Updated: 2016-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
800 participants
OBSERVATIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Participation in a Research Registry for Immune Disorders
NCT01953016
Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms
NCT00015431
Intensive Care Unit and Secondary and Primary Immune Deficiency
NCT02888535
Severe PID With Lymphoproliferation and Neutropenia
NCT03427593
Evaluation of Patients With Immune Function Abnormalities
NCT00128973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Furthermore the database can be used for the submission and storage of molecular diagnostic results and thus allow the compilation of genotype and phenotype observations, which is of essential and immediate use for the patient himself and patient care. An attending physician may gain information on similar cases of a rare PID disease in Switzerland and European countries and use these insights for therapy. In addition, it will be possible to obtain an insight on side effects. Thus, the system also meets the requirements of an optimal platform for Phase IV studies of post-licensing drug surveillance-programs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary Immunodeficiency Disease
Patients with primary Immunodeficiency disease (PID)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Basel
OTHER
University of Bern
OTHER
University Hospital, Geneva
OTHER
University of Lausanne
OTHER
Cantonal Hospital of St. Gallen
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arthur Helbling, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Bern, Inselspital
Christoph Hess, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Basel, University Hospital
Ayse H Ozsahin, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Geneva, University Hospital
Francois Spertini, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Lausanne, University Hospital
Hugo Ubieto, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital of Eastern Switzerland, St. Gallen
Reinhard A Seger, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Zürich, University Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, , Switzerland
University Hospital Bern
Bern, , Switzerland
University Children's Hospital Geneva
Geneva, , Switzerland
University Hospital Lausanne
Lausanne, , Switzerland
Children's Hospital of Eastern Switzerland and Cantonal Hospital
Sankt Gallen, , Switzerland
University Children's Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PID_CH_Registry06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.